T. Griffin
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Colorectal Cancer Screening and Detection
- Dermatology top 1%
- Chemotherapy-related skin toxicity
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 9
-
- Chemotherapy-related skin toxicity 5
- Co-authors
- B OsterwalderJoanne L. BlumStephen E. JonesAman U. BuzdarIrene KuterCharles L. VogelPatricia LoRussoBruno Reigner
- Journals
- Journal of Clinical Oncology (8 papers)Annals of Oncology (2 papers)Investigational New Drugs (1 paper)Clinical Cancer Research (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
T. Griffin
20 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 1.5k
- Dermatology 407
- Cancer Research 319
- Pulmonary and Respiratory Medicine 349
- Hematology 102
Countries citing papers authored by T. Griffin
This map shows the geographic impact of T. Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Griffin more than expected).
Fields of papers citing papers by T. Griffin
This network shows the impact of papers produced by T. Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Griffin. The network helps show where T. Griffin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside T. Griffin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2011 | 176 | |
| 3 | 2007 | 31 | |
| 4 | 2006 | 14 | |
| 5 | 2006 | 5 | |
| 6 | 2004 | 2 | |
| 7 | 2004 | 131 | |
| 8 | 2004 | 16 | |
| 9 | 2004 | 5 | |
| 10 | 2001 | 39 | |
| 11 | [A comparative randomized phase-II study of Xeloda (capecitabine) and paclitaxel in patients with breast cancer progressing after anthracycline antibiotics]. | 2000 | 4 |
| 12 | 1999 | 69 | |
| 13 | 1999 | 38 | |
| 14 | Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer Hit paper breakdown → | 1999 | 655 |
| 15 | 1998 | 224 | |
| 16 | 1998 | 221 | |
| 17 | A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors. | 1998 | 75 |
| 18 | 1983 | 49 | |
| 19 | Treatment of acute nonlymphocytic leukemia with neocarzinostatin. | 1980 | 6 |
| 20 | Pulmonary reaction associated with neocarzinostatin therapy. | 1978 | 15 |
About T. Griffin
T. Griffin is a scholar working on Oncology, Dermatology, Cancer Research, Hematology and Urology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Colorectal Cancer Treatments and Studies (9 papers), Chemotherapy-related skin toxicity (5 papers), Cancer therapeutics and mechanisms (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Breast Cancer Treatment Studies (2 papers), Neuroblastoma Research and Treatments (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Oncology (1.5k citations), Dermatology (407 citations), Cancer Research (319 citations), Pulmonary and Respiratory Medicine (349 citations) and Hematology (102 citations). T. Griffin has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include B Osterwalder, Joanne L. Blum, Stephen E. Jones, Aman U. Buzdar, Irene Kuter, Charles L. Vogel, Patricia LoRusso, Bruno Reigner, Peter W. Rose and Richard D Neal. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Investigational New Drugs, Clinical Cancer Research and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.